Authors: Witzig, TE Meyers, C Therneau, T Greipp, PR

Citation: Te. Witzig et al., A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders, LEUK LYMPH, 38(3-4), 2000, pp. 345

Authors: Lindor, KD Poupon, R Poupon, R Heathcote, EJ Therneau, T

Citation: Kd. Lindor et al., Ursodeoxycholic acid for primary biliary cirrhosis, LANCET, 355(9204), 2000, pp. 657-658

Authors: Figueiredo, F Dickson, ER Pasha, T Kasparova, P Therneau, T Malinchoc, M DiCecco, S Francisco-Ziller, N Charlton, M

Citation: F. Figueiredo et al., Impact of nutritional status on outcomes after liver transplantation, TRANSPLANT, 70(9), 2000, pp. 1347-1352

Authors: Krowka, MJ Wiseman, GA Burnett, OL Spivey, JR Therneau, T Porayko, MK Wiesner, RH

Citation: Mj. Krowka et al., Hepatopulmonary syndrome - A prospective study of relationships between severity of liver disease, Pao(2) response to 100% oxygen, and brain uptake after Tc-99m MAA lung scanning, CHEST, 118(3), 2000, pp. 615-624

Authors: Pasha, T Heathcote, J Gabriel, S Cauch-Dudek, K Jorgensen, R Therneau, T Dickson, ER Lindor, KD

Citation: T. Pasha et al., Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 21-26

Authors: Witzig, TE Timm, M Larson, D Therneau, T Greipp, PR

Citation: Te. Witzig et al., Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders, BR J HAEM, 104(1), 1999, pp. 131-137